Safety of the PD-1 antibody pembrolizumab in patients with high-grade adverse events under ipilimumab treatment - Bender, Carolin; Enk, Alexander; Hassel, Jessica C. (Annals of oncology, 2016)
Gesehen am 18.01.2018